DOW CHEMICAL CO /DE/
SC 13D/A, 1997-01-30
CHEMICALS & ALLIED PRODUCTS
Previous: LIFECORE BIOMEDICAL INC, SC 13G/A, 1997-01-30
Next: DOW JONES & CO INC, SC 13G, 1997-01-30



                                
                                
               SECURITIES AND EXCHANGE COMMISSION
                    Washington, D. C.  20549
                                
                                
                         SCHEDULE 13D/A
            Under the Securities Exchange Act of 1934
                         Amendment No. 4
                                
                                
              _________MYCOGEN CORPORATION_________
                    (NAME OF SUBJECT COMPANY)
                                
                                
             Common Stock, par value $.001 per share
                (Including the Associated Rights)
                 (TITLE OF CLASS OF SECURITIES)
                                
                           628452 10 4
                         (CUSIP Number)
                                
                                
John Scriven                J. Pedro Reinhard         Louis W. Pribila
Vice President, General     President                 Vice President,
Counsel and Secretary       Rofan Services Inc.       Secretary and
The Dow Chemical Company    2030 Dow Center           General Counsel
2030 Dow Center             Midland, MI  48674        DowElanco
Midland, MI  48674          (517) 636-1000            9330 Zionsville Road
(517) 636-1000                                        Indianapolis, IN  46268
                                                      (317)337-3000


               (Name, Address and Telephone Number of Person
             Authorized to Receive Notices and Communications)
                                 
                                
                                
                          January 21, 1997
          (Date of Event which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this Schedule because of Rule 13d-
1(b)(3) or (4), check the following box [   ].


Check the following box if a fee is being paid with this
statement [  ].

<PAGE>
                      CUSIP No. 628452 10 4


1)  Name of Reporting Person           The Dow Chemical Company         
    and its I.R.S.                     I.R.S. Identification No.
    Identification No.                 38-1285128
                                 
                                       Rofan Services Inc.
                                       I.R.S. Identification No.
                                       38-2853855
                                 
                                       DowElanco
                                       I.R.S. Identification No.
                                       35-1781118
                                 


2)  Check the Appropriate Box          (a)     [    ]
    if a Member of a Group             (b)     [    ]


3)  SEC Use Only                 


4)  Source of Funds                    WC



5)  Check Box if Disclosure of   
    Legal Proceedings is Required      [    ]
    Pursuant to Items 2(d) or 2(e)



6)  Citizenship or Place of            The Dow Chemical Company - Delaware
    Organization                       Rofan Services Inc. - Delaware
                                       DowElanco - Indiana


Number of        7) Sole Voting Power         16,836,502
Shares of        ________________________________________________________
Beneficially     8) Shared Voting Power       0
Owned by         ________________________________________________________
Each Reporting   9) Sole Dispositive Power    16,836,502
Person With      ________________________________________________________
                10) Shared Dispositive Power  0
                 ________________________________________________________
<PAGE>


11) Aggregate Amount Beneficially                     
    owned by Each Reporting Person 
    as of January 24, 1997             16,836,502

12) Check Box if the Aggregate   
    Amount in Row (11) 
    Excludes Certain Shares            [    ]

13) Percent of Class             
    Represented by
    Amount in Row (11)                 54.6%

14) Type of Reporting Person     
                                 
    The Dow Chemical Company           CO
    Rofan Services Inc.                CO
    DowElanco                          PN



       This Amendment No. 4 is being filed to note the increase
in the reporting persons' ownership from 51.8% to 54.6%.  It
amends the original Schedule 13D filed by the reporting persons
on January 25, 1996, as amended by Amendment No. 1 filed on
February 27, 1996, Amendment No. 2 filed on June 7, 1996, and
Amendment No. 3 filed on December 4, 1996 (the "Schedule 13D").
All defined terms used but not otherwise defined herein have the
meanings assigned to those terms in the Schedule 13D.

Item 3.       Source and Amount of Funds or Other Consideration.

       This Item 3 is hereby amended by adding the following
paragraph to the end thereof.

       DowElanco obtained the funds required to effect the
transactions reported in Amendment No. 4 to Schedule 13D from
working capital and other internal sources.

Item 4.       Purpose of Transaction.

       Part (a) of this Item 4 is hereby amended by adding the
following information to the end thereof.

        (a)  Since the filing of Amendment No. 3 to the Schedule
13D, DowElanco has purchased a number of shares in open market
transactions.  Those transactions are summarized in the following
table:

<PAGE>

           Shares of                                
  Date    Common Stock     Price/Share        Total Price
                                                    
12/5/96       5,000         $18.2500          $ 91,250.00
 1/8/97       5,000          22.2500           111,250.00
 1/9/97       5,000          22.2000           111,000.00
1/10/97       5,000          23.4500           117,250.00
1/13/97       5,000          23.5750           117,875.00
1/14/97      15,000          23.2000           348,000.00
1/22/97      15,000          25.3750           380,625.00
1/24/97       5,000          24.8750           124,375.00


On January 21, 1997, DowElanco purchased directly from Kubota
Corporation, a Japanese Corporation ("Kubota"), 620,000 shares of
Common Stock at a purchase price of $21.8540 per share.  On
January 21, 1997, DowElanco also purchased directly from JT
America Inc., a New York corporation ("JTA"), 244,700 shares of
Common Stock at a purchase price of $22.2500 per share.  If,
during the twelve months following January 21, 1997, DowElanco
publicly tenders for additional Common Stock, the purchase price
for each share purchased from JTA in this transaction will be
increased by the amount, if any, that the tender price exceeds
$22.2500 per share.  The purpose of these transactions was to
increase DowElanco's ownership of Common Stock at prices and on
terms that DowElanco considers favorable.  From time to time,
DowElanco may acquire additional shares of Common Stock on terms
it considers favorable, subject to the percentage of ownership
limitations contained in the Exchange and Purchase Agreement.


Item 5.       Interest in Securities of the Issuer.

       Parts (a), (b), (d) and (e) of this Item 5 are hereby
amended in their entirety by replacing such sections with the
indicated texts.  Part (c) of Item 5 is hereby amended by adding
the noted text to the end thereof.

       (a)  DowElanco owns, and TDCC and Rofan indirectly own, an
aggregate of 16,836,502 shares of Common Stock which represent
approximately 54.6% of the total outstanding shares of Common
Stock.

       (b)  DowElanco has, and TDCC and Rofan indirectly have,
the sole power to vote or to direct the vote and sole power to
dispose or to direct the disposition of such 16,836,502 shares of
Common Stock.

       (c) Since the filing of Amendment No. 3 to Schedule 13D,
DowElanco has purchased (i)  60,000 shares of Common Stock in
open market transactions for an aggregate purchase price of
$1,401,625.00, (ii) 620,000 shares of Common Stock in a private

<PAGE>

transaction with Kubata for an aggregate purchase price of
$13,549,480.00, and (iii) 244,700 shares of Common Stock in a
private transaction with JTA for an aggregate purchase price of
$5,444,575.00.  These transactions are more fully described in
Item 4, Part (a) hereto.

       (d)  None of TDCC, Rofan, DowElanco or their respective
affiliates is known to have the right to receive or the power to
direct the receipt of dividends from, or the proceeds from the
sale of any shares of Common Stock other than the 16,836,502
shares of Common Stock acquired by DowElanco.

       (e)  Not applicable.


Item 7.  Material to be Filed as Exhibits

None.


                                
                            SIGNATURE
                                
       After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.

Dated:  January 30, 1997

          THE DOW CHEMICAL COMPANY

          By:     /s/
          Name:   J. Pedro Reinhard
          Title:  Executive Vice President and Chief Financial Officer


          ROFAN SERVICES INC.

          By:     /s/
          Name:   J. Pedro Reinhard
          Title:  President


          DOWELANCO

          By:     /s/
          Name:   Louis W. Pribila
          Title:  Vice President, Secretary and General Counsel




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission